LifeSciences

GSK to Cut Costs with £1.9bn Programme

GSK is initiating a £1.9bn cost-cutting strategy, which includes a £400m investment in UK life sciences over three years. The company will relocate over 1,000 scientists to a new Cambridge R&D hub, while closing its Stevenage facility by 2029.